Tag Archive for: Artios

Life science leaders give valuable advice on surviving a downturn  

The final panel at this year’s Anglonordic Life Science Conference was led by Mike Ward, Global Head of Life Sciences & Healthcare Thought Leadership at Clarivate, who asked life science leaders for their wisdom on the subject: “If I knew then, what I know now.”   The expert panel had a wealth of experience to draw […]

Arix Bioscience plc Interim results for the six months ended 30 June 2021

LONDON, 12 August 2021: Arix Bioscience plc (“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces its interim results for the period ended 30 June 2021. Read more

Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States

Cambridge, UK and New York, US, 24 September 2019. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Tania Dimitrova as Chief Business Officer and its expanded presence in the United States. Tania is based at Artios’s new offices […]

Artios Pharma CEO, Niall Martin is on a mission to put DNA repair on the map

Niall Martin is on a mission to put DNA repair on the map. He has already gone pretty far along the way to doing this, as the leader of the team that developed the blockbuster cancer drug Lynparza. He is now seeking to repeat this early success at Artios, where he is CEO. Martin talked […]